世界の血液腫瘍学検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemato Oncology Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5189
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、血液腫瘍学検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（白血病検査、急性骨髄性検査、多発性骨髄腫検査、その他）、用途別市場規模（臨床検査室、病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・血液腫瘍学検査の市場動向
・企業の競争状況、市場シェア
・血液腫瘍学検査の種類別市場規模と予測2016-2027（白血病検査、急性骨髄性検査、多発性骨髄腫検査、その他）
・血液腫瘍学検査の用途別市場規模と予測2016-2027（臨床検査室、病院）
・血液腫瘍学検査の北米市場規模2016-2027（アメリカ、カナダ）
・血液腫瘍学検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・血液腫瘍学検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・血液腫瘍学検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・血液腫瘍学検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche、Abbott Laboratories、Thermo Fisher Scientific、QIAGEN N.V.、Bio-Rad Laboratories、Illumina、MolecularMD、Invivoscribe、Asuragen、Adaptive Biotechnologies、ArcherDx、ARUP Laboratories）
・結論

Hemato Oncology Testing refers to the detection of common hematological tumors such as leukemia, multiple myeloma, and malignant lymphoma by means of analytical kits, etc.

Market Analysis and Insights: Global Hemato Oncology Testing Market
The global Hemato Oncology Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemato Oncology Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemato Oncology Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemato Oncology Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemato Oncology Testing market.

Global Hemato Oncology Testing Scope and Market Size
Hemato Oncology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemato Oncology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Leukemia Testing
Acute Myeloid Testing
Multiple Myeloma Testing
Other

Segment by Application
Clinical Laboratories
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Abbott Laboratories
Thermo Fisher Scientific
QIAGEN N.V.
Bio-Rad Laboratories
Illumina
MolecularMD
Invivoscribe
Asuragen
Adaptive Biotechnologies
ArcherDx
ARUP Laboratories

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Leukemia Testing
1.2.3 Acute Myeloid Testing
1.2.4 Multiple Myeloma Testing
1.2.5 Other
1.3 Market by Application
1.3.1 Global Hemato Oncology Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemato Oncology Testing Market Perspective (2016-2027)
2.2 Hemato Oncology Testing Growth Trends by Regions
2.2.1 Hemato Oncology Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2016-2021)
2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2022-2027)
2.3 Hemato Oncology Testing Industry Dynamic
2.3.1 Hemato Oncology Testing Market Trends
2.3.2 Hemato Oncology Testing Market Drivers
2.3.3 Hemato Oncology Testing Market Challenges
2.3.4 Hemato Oncology Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemato Oncology Testing Players by Revenue
3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2016-2021)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2016-2021)
3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
3.4 Global Hemato Oncology Testing Market Concentration Ratio
3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2020
3.5 Hemato Oncology Testing Key Players Head office and Area Served
3.6 Key Players Hemato Oncology Testing Product Solution and Service
3.7 Date of Enter into Hemato Oncology Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemato Oncology Testing Breakdown Data by Type
4.1 Global Hemato Oncology Testing Historic Market Size by Type (2016-2021)
4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2022-2027)

5 Hemato Oncology Testing Breakdown Data by Application
5.1 Global Hemato Oncology Testing Historic Market Size by Application (2016-2021)
5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemato Oncology Testing Market Size (2016-2027)
6.2 North America Hemato Oncology Testing Market Size by Type
6.2.1 North America Hemato Oncology Testing Market Size by Type (2016-2021)
6.2.2 North America Hemato Oncology Testing Market Size by Type (2022-2027)
6.2.3 North America Hemato Oncology Testing Market Size by Type (2016-2027)
6.3 North America Hemato Oncology Testing Market Size by Application
6.3.1 North America Hemato Oncology Testing Market Size by Application (2016-2021)
6.3.2 North America Hemato Oncology Testing Market Size by Application (2022-2027)
6.3.3 North America Hemato Oncology Testing Market Size by Application (2016-2027)
6.4 North America Hemato Oncology Testing Market Size by Country
6.4.1 North America Hemato Oncology Testing Market Size by Country (2016-2021)
6.4.2 North America Hemato Oncology Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hemato Oncology Testing Market Size (2016-2027)
7.2 Europe Hemato Oncology Testing Market Size by Type
7.2.1 Europe Hemato Oncology Testing Market Size by Type (2016-2021)
7.2.2 Europe Hemato Oncology Testing Market Size by Type (2022-2027)
7.2.3 Europe Hemato Oncology Testing Market Size by Type (2016-2027)
7.3 Europe Hemato Oncology Testing Market Size by Application
7.3.1 Europe Hemato Oncology Testing Market Size by Application (2016-2021)
7.3.2 Europe Hemato Oncology Testing Market Size by Application (2022-2027)
7.3.3 Europe Hemato Oncology Testing Market Size by Application (2016-2027)
7.4 Europe Hemato Oncology Testing Market Size by Country
7.4.1 Europe Hemato Oncology Testing Market Size by Country (2016-2021)
7.4.2 Europe Hemato Oncology Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemato Oncology Testing Market Size (2016-2027)
8.2 Asia-Pacific Hemato Oncology Testing Market Size by Type
8.2.1 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemato Oncology Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemato Oncology Testing Market Size by Application
8.3.1 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemato Oncology Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemato Oncology Testing Market Size by Region
8.4.1 Asia-Pacific Hemato Oncology Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemato Oncology Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemato Oncology Testing Market Size (2016-2027)
9.2 Latin America Hemato Oncology Testing Market Size by Type
9.2.1 Latin America Hemato Oncology Testing Market Size by Type (2016-2021)
9.2.2 Latin America Hemato Oncology Testing Market Size by Type (2022-2027)
9.2.3 Latin America Hemato Oncology Testing Market Size by Type (2016-2027)
9.3 Latin America Hemato Oncology Testing Market Size by Application
9.3.1 Latin America Hemato Oncology Testing Market Size by Application (2016-2021)
9.3.2 Latin America Hemato Oncology Testing Market Size by Application (2022-2027)
9.3.3 Latin America Hemato Oncology Testing Market Size by Application (2016-2027)
9.4 Latin America Hemato Oncology Testing Market Size by Country
9.4.1 Latin America Hemato Oncology Testing Market Size by Country (2016-2021)
9.4.2 Latin America Hemato Oncology Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemato Oncology Testing Market Size (2016-2027)
10.2 Middle East & Africa Hemato Oncology Testing Market Size by Type
10.2.1 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemato Oncology Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemato Oncology Testing Market Size by Application
10.3.1 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemato Oncology Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemato Oncology Testing Market Size by Country
10.4.1 Middle East & Africa Hemato Oncology Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemato Oncology Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Hemato Oncology Testing Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hemato Oncology Testing Introduction
11.2.4 Abbott Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Hemato Oncology Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Details
11.4.2 QIAGEN N.V. Business Overview
11.4.3 QIAGEN N.V. Hemato Oncology Testing Introduction
11.4.4 QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2016-2021)
11.4.5 QIAGEN N.V. Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Hemato Oncology Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Hemato Oncology Testing Introduction
11.6.4 Illumina Revenue in Hemato Oncology Testing Business (2016-2021)
11.6.5 Illumina Recent Development
11.7 MolecularMD
11.7.1 MolecularMD Company Details
11.7.2 MolecularMD Business Overview
11.7.3 MolecularMD Hemato Oncology Testing Introduction
11.7.4 MolecularMD Revenue in Hemato Oncology Testing Business (2016-2021)
11.7.5 MolecularMD Recent Development
11.8 Invivoscribe
11.8.1 Invivoscribe Company Details
11.8.2 Invivoscribe Business Overview
11.8.3 Invivoscribe Hemato Oncology Testing Introduction
11.8.4 Invivoscribe Revenue in Hemato Oncology Testing Business (2016-2021)
11.8.5 Invivoscribe Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Details
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hemato Oncology Testing Introduction
11.9.4 Asuragen Revenue in Hemato Oncology Testing Business (2016-2021)
11.9.5 Asuragen Recent Development
11.10 Adaptive Biotechnologies
11.10.1 Adaptive Biotechnologies Company Details
11.10.2 Adaptive Biotechnologies Business Overview
11.10.3 Adaptive Biotechnologies Hemato Oncology Testing Introduction
11.10.4 Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2016-2021)
11.10.5 Adaptive Biotechnologies Recent Development
11.11 ArcherDx
11.11.1 ArcherDx Company Details
11.11.2 ArcherDx Business Overview
11.11.3 ArcherDx Hemato Oncology Testing Introduction
11.11.4 ArcherDx Revenue in Hemato Oncology Testing Business (2016-2021)
11.11.5 ArcherDx Recent Development
11.12 ARUP Laboratories
11.12.1 ARUP Laboratories Company Details
11.12.2 ARUP Laboratories Business Overview
11.12.3 ARUP Laboratories Hemato Oncology Testing Introduction
11.12.4 ARUP Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)
11.12.5 ARUP Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Leukemia Testing
Table 3. Key Players of Acute Myeloid Testing
Table 4. Key Players of Multiple Myeloma Testing
Table 5. Key Players of Other
Table 6. Global Hemato Oncology Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemato Oncology Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemato Oncology Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemato Oncology Testing Market Share by Regions (2016-2021)
Table 10. Global Hemato Oncology Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Hemato Oncology Testing Market Share by Regions (2022-2027)
Table 12. Hemato Oncology Testing Market Trends
Table 13. Hemato Oncology Testing Market Drivers
Table 14. Hemato Oncology Testing Market Challenges
Table 15. Hemato Oncology Testing Market Restraints
Table 16. Global Hemato Oncology Testing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Hemato Oncology Testing Market Share by Players (2016-2021)
Table 18. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2020)
Table 19. Ranking of Global Top Hemato Oncology Testing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Hemato Oncology Testing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemato Oncology Testing Product Solution and Service
Table 23. Date of Enter into Hemato Oncology Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Hemato Oncology Testing Revenue Market Share by Type (2016-2021)
Table 27. Global Hemato Oncology Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Hemato Oncology Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Hemato Oncology Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Hemato Oncology Testing Revenue Market Share by Application (2016-2021)
Table 31. Global Hemato Oncology Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Hemato Oncology Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hemato Oncology Testing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Hemato Oncology Testing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Hemato Oncology Testing Product
Table 66. F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Hemato Oncology Testing Product
Table 71. Abbott Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 72. Abbott Laboratories Recent Development
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific Hemato Oncology Testing Product
Table 76. Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Development
Table 78. QIAGEN N.V. Company Details
Table 79. QIAGEN N.V. Business Overview
Table 80. QIAGEN N.V. Hemato Oncology Testing Product
Table 81. QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 82. QIAGEN N.V. Recent Development
Table 83. Bio-Rad Laboratories Company Details
Table 84. Bio-Rad Laboratories Business Overview
Table 85. Bio-Rad Laboratories Hemato Oncology Testing Product
Table 86. Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 87. Bio-Rad Laboratories Recent Development
Table 88. Illumina Company Details
Table 89. Illumina Business Overview
Table 90. Illumina Hemato Oncology Testing Product
Table 91. Illumina Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 92. Illumina Recent Development
Table 93. MolecularMD Company Details
Table 94. MolecularMD Business Overview
Table 95. MolecularMD Hemato Oncology Testing Product
Table 96. MolecularMD Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 97. MolecularMD Recent Development
Table 98. Invivoscribe Company Details
Table 99. Invivoscribe Business Overview
Table 100. Invivoscribe Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 101. Invivoscribe Recent Development
Table 102. Asuragen Company Details
Table 103. Asuragen Business Overview
Table 104. Asuragen Hemato Oncology Testing Product
Table 105. Asuragen Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 106. Asuragen Recent Development
Table 107. Adaptive Biotechnologies Company Details
Table 108. Adaptive Biotechnologies Business Overview
Table 109. Adaptive Biotechnologies Hemato Oncology Testing Product
Table 110. Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 111. Adaptive Biotechnologies Recent Development
Table 112. ArcherDx Company Details
Table 113. ArcherDx Business Overview
Table 114. ArcherDx Hemato Oncology Testing Product
Table 115. ArcherDx Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 116. ArcherDx Recent Development
Table 117. ARUP Laboratories Company Details
Table 118. ARUP Laboratories Business Overview
Table 119. ARUP Laboratories Hemato Oncology Testing Product
Table 120. ARUP Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)
Table 121. ARUP Laboratories Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemato Oncology Testing Market Share by Type: 2020 VS 2027
Figure 2. Leukemia Testing Features
Figure 3. Acute Myeloid Testing Features
Figure 4. Multiple Myeloma Testing Features
Figure 5. Other Features
Figure 6. Global Hemato Oncology Testing Market Share by Application: 2020 VS 2027
Figure 7. Clinical Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Hemato Oncology Testing Report Years Considered
Figure 10. Global Hemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hemato Oncology Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemato Oncology Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Hemato Oncology Testing Market Share by Regions (2022-2027)
Figure 14. Global Hemato Oncology Testing Market Share by Players in 2020
Figure 15. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2020
Figure 17. Global Hemato Oncology Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Hemato Oncology Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hemato Oncology Testing Market Share by Type (2016-2027)
Figure 21. North America Hemato Oncology Testing Market Share by Application (2016-2027)
Figure 22. North America Hemato Oncology Testing Market Share by Country (2016-2027)
Figure 23. United States Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hemato Oncology Testing Market Share by Type (2016-2027)
Figure 27. Europe Hemato Oncology Testing Market Share by Application (2016-2027)
Figure 28. Europe Hemato Oncology Testing Market Share by Country (2016-2027)
Figure 29. Germany Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hemato Oncology Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hemato Oncology Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hemato Oncology Testing Market Share by Region (2016-2027)
Figure 39. China Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hemato Oncology Testing Market Share by Type (2016-2027)
Figure 47. Latin America Hemato Oncology Testing Market Share by Application (2016-2027)
Figure 48. Latin America Hemato Oncology Testing Market Share by Country (2016-2027)
Figure 49. Mexico Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hemato Oncology Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hemato Oncology Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hemato Oncology Testing Market Share by Country (2016-2027)
Figure 55. Turkey Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 59. Abbott Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 61. QIAGEN N.V. Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 63. Illumina Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 64. MolecularMD Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 65. Invivoscribe Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 66. Asuragen Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 67. Adaptive Biotechnologies Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 68. ArcherDx Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 69. ARUP Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界のDNA診断/検査市場規模・現状・予測（2021年-2027年）

Global DNA Diagnostics/Testing Market Size, Status and Forecast 2021-2027
QFJ1-4145 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、DNA診断/検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCRベース診断、NGS DNA診断、in-situハイブリダイゼーション診断、マイクロアレイベース診断）、用途別市場規模（腫瘍学診断＆...

世界の腫瘍バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Oncology Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4604 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腫瘍バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（診断、創薬・開発、予後、リスクアセスメント、その他）、主要地域別市場規模（北米、アメリカ...

世界のコンパニオン腫瘍診断市場規模・現状・予測（2021年-2027年）

Global Oncology Companion Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-5273 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、コンパニオン腫瘍診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、免疫組織化学（IHC）、インサイチューハイブリダイゼーション（ISH...

世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年）

Global Immuno Oncology Assays Market Size, Status and Forecast 2021-2027
QFJ1-4349 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、免疫腫瘍学アッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）、用途別市場規模（研究所、臨床診断）、主要地域別市場規模（北米、ア...

世界のSTD診断検査市場規模・現状・予測（2021年-2027年）

Global Diagnostic Testing For STDs Market Size, Status and Forecast 2021-2027
QFJ1-4128 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、STD診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（梅毒検査、淋病検査、クラミジア検査、単純ヘルペスウイルス検査、ヒト免疫不全ウイルス検査、ヒトパピローマウイルス検査、その他）、用途別市場規...

世界の抗生物質感受性試験市場規模・現状・予測（2021年-2027年）

Global Antibiotic Sensitivity Testing Market Size, Status and Forecast 2021-2027
QFJ1-3820 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、抗生物質感受性試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手動式感受性試験システム、自動式感受性試験システム）、用途別市場規模（創薬＆開発、臨床診断薬、疫学、その他）、主要地域別市場規模（北米...

世界の特定タンパク質検査市場規模・現状・予測（2021年-2027年）

Global Specific Protein Testing Market Size, Status and Forecast 2021-2027
QFJ1-4888 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、特定タンパク質検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポリポタンパク質C-II、アポリポタンパク質C-III、アポリポタンパク質E、その他）、用途別市場規模（病院、クリニック、診断研究所...

世界のアンチトロンビンIIIテスト市場規模・現状・予測（2021年-2027年）

Global Anti-thrombin III Testing Market Size, Status and Forecast 2021-2027
QFJ1-3841 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、アンチトロンビンIIIテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンチトロンビン欠乏症診断、活性アッセイ、免疫学アッセイ）、用途別市場規模（病院、研究機関、診療所、その他）、主要地域別市場...

世界の酵素免疫測定法（ELISA）検査市場規模・現状・予測（2021年-2027年）

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-4193 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、酵素免疫測定法（ELISA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サンドイッチELISA、間接ELISA、マルチポータブルELISA、競合ELISA）、用途別市場規模（病院＆診断センター...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年） Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool. Market Analysis and Insights: Global Oncology Blood Testing Market The global Oncology Blood Testing market size is p…
世界の獣医におけるヘモグロビンA1C検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hemoglobin A1C Testing in Veterinary Market The global Hemoglobin A1C Testing in Veterinary market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界のDNA診断/検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global DNA Diagnostics/Testing Market The global DNA Diagnostics/Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界の酵素免疫測定法（ELISA）検査市場規模・現状・予測（2021年-2027年） Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors …
世界のウエストナイルウイルス検査市場規模・現状・予測（2021年-2027年） West Nile virus is a tropical and temperate virus. It mainly infects birds, but also humans, horses, cats, skunks, gray rats, and domestic rabbits. The main route of transmission in humans is the bite of an infected mosquito. Market Analysis and Insights: Global West Nile Virus Testing Market The gl…